-
Posted: October 14th, 2024, 11:00pm UTC
Conditions: Urachal Cancer; Parathyroid Carcinoma; Fibrolamellar Carcinoma; Angiosarcoma; Secretory Carcinoma of Breast; Anal Neoplasms; Metaplastic Breast Carcinoma; Translocation Renal Cell Carcinoma; Carcinosarcoma; Small Intestine Neoplasms; Cholangiocarcinoma; Sertoli-Leydig Cell Tumor; Adenoid Cystic Carcinoma; Mesothelioma; Neuroblastoma; Adrenal Gland Neoplasms; Penile Neoplasms; Apocrine Carcinoma; Fibrosarcoma; Cancer of Unknown Primary; Hemangioblastoma; Thyroid Neoplasms; Hepatoblastoma; Fallopian Tube Neoplasms; Leiomyosarcoma; Vaginal Neoplasms; Neurofibrosarcoma; Gallbladder Neoplasms; Osteosarcoma; Biliary Tract Neoplasms; Clear Cell Endometrial Cancer; Yolk Sac Tumor; Vulvar Neoplasms; Kaposi Sarcoma; Ovarian Epithelial Cancer; Soft Tissue Sarcoma; Urethral Neoplasms; Granulosa Cell Tumor; Primitive Neuroectodermal Tumor; Neuroendocrine Tumors; Trophoblastic Tumor
Interventions: Drug: Nivolumab
Sponsors: Instituto do Cancer do Estado de São Paulo; Financiadora de Estudos e Projetos
Recruiting
-
Posted: October 10th, 2024, 11:00pm UTC
Conditions: Thoracic Cancer; Head and Neck Cancer; Pelvic Cancer; Hepatobiliary Carcinoma in Situ; Retroperitoneal Cancer; Distributed and Orphan Tumors
Interventions: Device: RefleXion X1 Radiotherapy System [Imaging Only]
Sponsors: RefleXion Medical
Not yet recruiting
-
Posted: October 1st, 2024, 11:00pm UTC
Conditions: NSCLC
Interventions: Biological: Blood samples for Hematology; Biological: Blood samples for Chemistry; Biological: Blood sample for liver function tests; Biological: Pregnancy test; Procedure: Tumour assessment; Procedure: Local Ablative Therapy (LAT)
Sponsors: Groupe Francais De Pneumo-Cancerologie
Not yet recruiting
-
Posted: September 9th, 2024, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Triprolizumab; Device: rodiotherapy
Sponsors: Sun Yat-sen University
Not yet recruiting
-
Posted: August 1st, 2024, 11:00pm UTC
Conditions: Endometrial Neoplasms; Neoplasm Recurrence, Local; Neoplasm Metastasis
Interventions: Drug: Paclitaxel and Cisplatin; Drug: Cadonilimab; Radiation: Radiotherapy
Sponsors: Shandong Cancer Hospital and Institute
Recruiting
-
Posted: July 23rd, 2024, 11:00pm UTC
Conditions: Ovarian Cancer; Antiangiogenic-Associated Hypertension; Adjuvant Bevacizumab; Hypertension
Interventions: Drug: arm A - angiotensin converting enzyme inhibitors (ACEi); Drug: arm B - calcium channel blockers (CCBs); Drug: arm R - angiotensin receptor blockers ARB
Sponsors: Groupe Hospitalier Pitie-Salpetriere; Dr Floriane Jochum, Principal Investigator; Institut Curie
Active, not recruiting
-
Posted: July 16th, 2024, 11:00pm UTC
Conditions: Pancreatic Ductal Adenocarcinoma; Cholangiocarcinoma; Gastric Cancer; Bladder Cancer; Hepatocellular Carcinoma; Pheochromocytoma; Ovarian Cancer
Interventions: Drug: [18F]FAPI-74; Drug: [18F]FDG
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: July 4th, 2024, 11:00pm UTC
Conditions: Adrenocortical Carcinoma (ACC); Recurrent Adrenocortical Carcinoma (ACC); Recurrent Abdominal Adrenocortical Carcinoma (ACC); Carcinoma, Adrenocortical; Carcinoma, Adrenal Cortical
Interventions: Radiation: Preoperative external beam radiation therapy (EBRT); Procedure: Surgical resection
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: June 28th, 2024, 11:00pm UTC
Conditions: Head and Neck Tumors; Kidney Cancers; Small Cell Lung Cancers; Pheochromocytoma/Paragangliomas; Gastrointestinal Neuroendocrine Tumors; Somatostatin Receptor Positive
Interventions: Drug: 68Ga-DOTATATE; Drug: [203Pb]VMT-alpha-NET; Drug: [212Pb]VMT-alpha-NET
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
-
Posted: June 21st, 2024, 11:00pm UTC
Conditions: Gastric Cancer; GastroEsophageal Cancer
Interventions: Procedure: Radical surgery; Drug: PD-1 Monoclonal Antibody; Drug: XELOX Chemotherapy Regimen; Procedure: Local Treatment
Sponsors: Shanghai Zhongshan Hospital
Not yet recruiting
-
Posted: April 2nd, 2024, 11:00pm UTC
Conditions: Lung Cancer; Liver Cancer; Pancreatic Cancer; Renal Cell Carcinoma
Interventions: Radiation: SBRT
Sponsors: Peking University Third Hospital
Recruiting
-
Posted: March 27th, 2024, 11:00pm UTC
Conditions: Pancreatic Adenocarcinoma; Ampulla of Vater Carcinoma; Adrenocortical Carcinoma; Neuroendocrine Carcinoma; Soft Tissue Sarcoma; Small Bowel Adenocarcinoma; Duodenum Adenocarcinoma; Gastric Adenocarcinoma
Interventions: Drug: Dostarlimab; Drug: Chemotherapy
Sponsors: UNICANCER; National Cancer Institute, France; GlaxoSmithKline
Recruiting
-
Posted: February 28th, 2024, 1:00am UTC
Conditions: Carcinoma Adrenal; Carcinoma, Adrenocortical Recurrent
Sponsors: Latin American Cooperative Oncology Group
Not yet recruiting
-
Posted: January 29th, 2024, 1:00am UTC
Conditions: Adrenal Tumor; Primary Aldosteronism; Cushing Syndrome; Pheochromocytoma; Adrenal Cortical Carcinoma
Sponsors: Seoul National University Hospital; Asan Medical Center; Seoul National University Bundang Hospital; Samsung Medical Center; Inha University Hospital; Chonnam National University Hospital; Nowon Eulji Medical Center
Recruiting
-
Posted: January 15th, 2024, 1:00am UTC
Conditions: NSCLC; NSCLC Stage IV; Oligometastatic Disease; Non Small Cell Lung Cancer; Non Small Cell Lung Cancer Metastatic; EGF-R Positive Non-Small Cell Lung Cancer; NSCLC Stage IV Without EGFR/ALK Mutation; Non-Small Cell Adenocarcinoma; Non-Small Cell Squamous Lung Cancer; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor; Synchronous Metastases; Metachronous Metastasis
Interventions: Radiation: Stereotactic Ablative Radiotherapy
Sponsors: Radiotherapy Oncology Centre "Santa Maria" Hospital; Paola Anselmo,MD; Michelina Casale,PhD; Fabio Trippa,MD
Recruiting
-
Posted: January 4th, 2024, 1:00am UTC
Conditions: Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy
Interventions: Combination Product: PD-1 inhibitor+/- chemotherapy combined with local therapy; Drug: systemic therapy alone
Sponsors: Fudan University
Recruiting
-
Posted: November 21st, 2023, 1:00am UTC
Conditions: Adrenal Cortical Carcinoma; Medullary Thyroid Cancer; Thymic Neuroendocrine Carcinoma; Pancreatic Neuroendocrine Tumor
Interventions: Biological: individualized mRNA neoantigen vaccine (mRNA-0523-L001)
Sponsors: Shanghai Jiao Tong University School of Medicine
Recruiting
-
Posted: October 4th, 2023, 11:00pm UTC
Conditions: Adrenocortical Carcinoma; ACC; Metastatic Adrenocortical Carcinoma
Interventions: Radiation: Ablative Radiotherapy; Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
-
Posted: August 22nd, 2023, 11:00pm UTC
Conditions: Advanced Solid Tumor; Hepatocellular Carcinoma
Interventions: Drug: TORL-4-500
Sponsors: TORL Biotherapeutics, LLC; Translational Research in Oncology
Recruiting
-
Posted: August 21st, 2023, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: 68Ga-R8760 injection at pre-defined dose levels; Drug: 68Ga-R8760 injection
Sponsors: Radionetics Oncology
Active, not recruiting
-
Posted: June 22nd, 2023, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG; Drug: Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
Sponsors: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Recruiting
-
Posted: May 30th, 2023, 11:00pm UTC
Conditions: Cushing Syndrome; Fatty Liver Disease
Interventions: Diagnostic Test: hepatic MRI
Sponsors: University Hospital, Angers
Recruiting
-
Posted: May 23rd, 2023, 11:00pm UTC
Conditions: Hepatocellular Carcinoma
Interventions: Diagnostic Test: 18F-FDGal PET/CT or PET/MRI
Sponsors: University of Aarhus
Recruiting
-
Posted: April 28th, 2023, 11:00pm UTC
Conditions: Squamous Cell Carcinoma of the Head and Neck; Paclitaxel; Carboplatin; Nivolumab
Interventions: Drug: GCP intratumoral catheter
Sponsors: Centre Hospitalier Universitaire, Amiens
Not yet recruiting
-
Posted: March 6th, 2023, 1:00am UTC
Conditions: Cancer; Adrenal
Interventions: Other: Blood sample; Other: Urine sample; Other: Tumor sample
Sponsors: Assistance Publique - Hôpitaux de Paris; National Cancer Institute, France
Recruiting
-
Posted: December 6th, 2022, 1:00am UTC
Conditions: Essential Hypertension; Liver Cancer; Nasopharyngeal Cancer; Pancreatic Cancer; Lung Cancer; Chronic Kidney Diseases; Acute Coronary Syndrome; Epilepsy; Gastric Cancer; Primary Aldosteronism; Subclinical hypothyroïdism
Interventions: Other: no intervention
Sponsors: Zhujiang Hospital; National Natural Science Foundation of China
Recruiting
-
Posted: December 2nd, 2022, 1:00am UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Mitotane; Drug: Pembrolizumab
Sponsors: M.D. Anderson Cancer Center
Completed
-
Posted: February 14th, 2022, 1:00am UTC
Conditions: Neuroendocrine Tumors; Carcinoma, Neuroendocrine
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: June 25th, 2021, 11:00pm UTC
Conditions: Metastatic Carcinoma
Interventions: Radiation: Stereotactic ablative body radiation therapy
Sponsors: Baptist Health South Florida; Viewray Inc.
Active, not recruiting
-
Posted: May 21st, 2021, 11:00pm UTC
Conditions: Pediatric Solid Tumor; Osteosarcoma; Rhabdomyosarcoma; Neuroblastoma; Ewing Sarcoma; Wilms Tumor; Adrenocortical Cancer; Desmoplastic Small Round Cell Tumor; Germ Cell Cancer; Rhabdoid Tumor; Clear Cell Sarcoma; Hepatoblastoma; Melanoma; Carcinoma; Malignant Peripheral Nerve Sheath Tumors; Soft Tissue Sarcoma
Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Drug: MESNA; Drug: B7-H3 CAR T cells
Sponsors: St. Jude Children's Research Hospital
Recruiting
-
Posted: March 5th, 2021, 1:00am UTC
Conditions: Advanced Lung Carcinoma; Advanced Malignant Solid Neoplasm; Malignant Adrenal Gland Neoplasm; Metastatic Liver Carcinoma; Metastatic Lung Carcinoma; Metastatic Malignant Solid Neoplasm; Stage III Liver Cancer; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Liver Cancer; Stage IV Lung Cancer AJCC v8; Stage IVA Liver Cancer; Stage IVA Lung Cancer AJCC v8; Stage IVB Liver Cancer; Stage IVB Lung Cancer AJCC v8
Interventions: Biological: Anti-CTLA4 Monoclonal Antibody BMS-986218; Biological: Nivolumab; Radiation: Stereotactic Body Radiation Therapy
Sponsors: M.D. Anderson Cancer Center
Active, not recruiting
-
Posted: August 13th, 2020, 11:00pm UTC
Conditions: Carcinomatosis, Peritoneal; Pancreas Cancer; Ovarian Cancer; Colon Cancer
Interventions: Procedure: MRI
Sponsors: University Hospital, Ghent
Recruiting
-
Posted: July 7th, 2020, 11:00pm UTC
Conditions: Bladder Carcinoma; Cervical Carcinoma; Cholangiocarcinoma; Hematopoietic and Lymphoid Cell Neoplasm; Hepatocellular Carcinoma; Malignant Adrenal Gland Neoplasm; Malignant Brain Neoplasm; Malignant Pleural Neoplasm; Malignant Skin Neoplasm; Malignant Solid Neoplasm; Malignant Testicular Neoplasm; Malignant Thymus Neoplasm; Neuroendocrine Neoplasm; Thyroid Gland Carcinoma; Urothelial Carcinoma; Cancer of Unknown Primary Site
Interventions: Procedure: Computed Tomography; Drug: Gallium Ga 68 FAPi-46; Procedure: Positron Emission Tomography; Radiation: 18F-FDG
Sponsors: Jonsson Comprehensive Cancer Center
Recruiting
-
Posted: May 4th, 2020, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Relacorilant; Drug: Pembrolizumab
Sponsors: Corcept Therapeutics
Completed
-
Posted: April 22nd, 2020, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: March 24th, 2020, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Camrelizumab
Sponsors: West China Hospital
Recruiting
-
Posted: December 5th, 2019, 1:00am UTC
Conditions: Adrenocortical Carcinoma; Pheochromocytoma; Paraganglioma
Interventions: Biological: EO2401; Biological: Nivolumab
Sponsors: Enterome
Active, not recruiting
-
Posted: October 8th, 2019, 11:00pm UTC
Conditions: Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Pathologic Stage IIIC Cutaneous Melanoma AJCC v8; Pathologic Stage IV Cutaneous Melanoma AJCC v8; Recurrent Malignant Solid Neoplasm; Refractory Malignant Solid Neoplasm; Uveal Melanoma; Acral Melanoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Adrenocortical Carcinoma; Pancreatic Neuroendocrine Tumor; Thyroid Cancer; Breast Cancer; Lung Adenocarcinoma; Head and Neck Squamous Cell Carcinoma
Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Drug: Cyclophosphamide; Drug: Fludarabine Phosphate; Other: Fludeoxyglucose F-18; Biological: IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography
Sponsors: Jonsson Comprehensive Cancer Center; Parker Institute for Cancer Immunotherapy; City of Hope National Medical Center; Melanoma Research Alliance; California Institute for Regenerative Medicine (CIRM)
Recruiting
-
Posted: October 3rd, 2019, 11:00pm UTC
Conditions: Pancreas Cancer; Lung Cancer; Renal Cancer; Adrenal Metastases; Prostate Cancer; Liver Metastases; Oligoprogressive Nodal Metastases; Metachronous Nodal Metastases; Synchronous Nodal Metastases; Mesothelioma; Spine Metastases; Brain Metastases; Borderline Resectable Pancreatic Carcinoma
Interventions: Radiation: MR-guided Linac
Sponsors: Dana-Farber Cancer Institute
Suspended
-
Posted: July 29th, 2019, 11:00pm UTC
Conditions: Non-Small Cell Lung Cancer
Interventions: Drug: Osimertinib; Drug: Pemetrexed/Carboplatin; Drug: Pemetrexed/Cisplatin
Sponsors: AstraZeneca
Active, not recruiting
-
Posted: January 10th, 2019, 1:00am UTC
Conditions: Advanced Solid Tumors
Interventions: Drug: ASP1951; Drug: pembrolizumab
Sponsors: Astellas Pharma Global Development, Inc.; Merck Sharp & Dohme LLC
Terminated
-
Posted: November 21st, 2018, 1:00am UTC
Conditions: Von Hippel-Lindau Disease; Hereditary Leiomyomatosis and Renal Cell Cancer; Birt-Hogg-Dube Syndrome; SDHB Gene Mutation
Sponsors: Joshua Mann, MPH; National Organization for Rare Disorders
Recruiting
-
Posted: November 20th, 2018, 1:00am UTC
Conditions: Renal Tumor
Interventions: Radiation: Stereotactic Ablative Radiotherapy
Sponsors: University Health Network, Toronto
Recruiting
-
Posted: November 19th, 2018, 1:00am UTC
Conditions: Advanced Solid Tumours; Endometrial Cancer; Cervical Cancer; Ovarian Cancer; Breast Cancer; Triple Negative Breast Cancer (TNBC); HER2-negative Breast Cancer; Head and Neck Squamous Cell Carcinoma (HNSCC); Adrenocortical Carcinoma; Uveal Melanoma
Interventions: Drug: [111In]-FPI-1547 Injection; Drug: [225Ac]-FPI-1434 Injection multi-dose; Biological: FPI-1175 Infusion; Drug: [225Ac]-FPI-1434 Injection single-dose
Sponsors: Fusion Pharmaceuticals Inc.
Recruiting
-
Posted: November 14th, 2018, 1:00am UTC
Conditions: Malignant Solid Tumors; Other Neoplasms Solid Tumors; Pediatric Solid Tumor; Refractory Solid Tumors; Solid Tumor
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: October 30th, 2018, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Cisplatin plus Etoposide; Other: Observation or Mitotane
Sponsors: Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Completed
-
Posted: October 24th, 2018, 11:00pm UTC
Conditions: NSCLC; Crizotinib; ALK Gene Rearrangement or ROS1 Gene Rearrangement
Sponsors: Pfizer; French College of General Hospital Pneumologists (CPHG)
Completed
-
Posted: August 2nd, 2018, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Cabozantinib-s-malate
Sponsors: Wuerzburg University Hospital
Active, not recruiting
-
Posted: July 27th, 2018, 11:00pm UTC
Conditions: Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Interventions: Drug: Niraparib; Drug: Dostarlimab (TSR-042); Drug: Standard of care; Drug: Dostarlimab-Placebo; Drug: Niraparib-Placebo
Sponsors: Tesaro, Inc.; European Network of Gynaecological Oncological Trial Groups (ENGOT)
Active, not recruiting
-
Posted: July 11th, 2018, 11:00pm UTC
Conditions: ENSAT Stage I Adrenal Cortex Carcinoma; ENSAT Stage II Adrenal Cortex Carcinoma; ENSAT Stage III Adrenal Cortex Carcinoma
Interventions: Drug: Cisplatin; Drug: Etoposide; Drug: Mitotane; Other: Quality-of-Life Assessment
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI); Assistance Publique - Hôpitaux de Paris
Recruiting
-
Posted: June 21st, 2018, 11:00pm UTC
Conditions: Advanced Solid Tumors
Interventions: Drug: ASP1948; Drug: nivolumab; Drug: pembrolizumab
Sponsors: Astellas Pharma Global Development, Inc.; Merck Sharp & Dohme LLC
Completed
-
Posted: December 12th, 2017, 1:00am UTC
Conditions: Metastatic Carcinoma in the Adrenal Cortex; Stage III Adrenal Cortex Carcinoma AJCC v8; Stage IV Adrenal Cortex Carcinoma AJCC v8; Unresectable Adrenal Cortex Carcinoma
Interventions: Drug: Cabozantinib; Other: Pharmacogenomic Study; Other: Pharmacokinetic Study
Sponsors: M.D. Anderson Cancer Center
Completed
-
Posted: November 7th, 2017, 1:00am UTC
Conditions: Genitourinary Cancer; Adrenocortical Carcinoma; Non-urothelial Bladder; Non-urothelial Upper Tract; Penile Cancer; Non-adenocarcinoma Prostate Cancer; Refractory Germ-cell; High Grade Neuroendocrine Carcinoma/Small Cell Carcinoma
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Dana-Farber Cancer Institute; Bristol-Myers Squibb
Active, not recruiting
-
Posted: April 25th, 2017, 11:00pm UTC
Conditions: Adrenocortical Carcinoma; Peritoneal Carcinomatosis
Interventions: Drug: Cisplatin; Drug: Sodium thiosulfate; Procedure: Cytoreductive surgery
Sponsors: Columbia University
Recruiting
-
Posted: February 10th, 2017, 1:00am UTC
Conditions: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease
Sponsors: St. Jude Children's Research Hospital
Recruiting
-
Posted: August 16th, 2016, 11:00pm UTC
Conditions: Adrenal Cortical Carcinoma; Alveolar Soft Part Sarcoma; Central Nervous System Neoplasm; Childhood Clear Cell Sarcoma of Soft Tissue; Clear Cell Sarcoma of Soft Tissue; Ewing Sarcoma; Hepatoblastoma; Hepatocellular Carcinoma; Osteosarcoma; Recurrent Adrenal Cortical Carcinoma; Recurrent Alveolar Soft Part Sarcoma; Recurrent Clear Cell Sarcoma of Soft Tissue; Recurrent Ewing Sarcoma; Recurrent Hepatoblastoma; Recurrent Hepatocellular Carcinoma; Recurrent Kidney Wilms Tumor; Recurrent Malignant Solid Neoplasm; Recurrent Osteosarcoma; Recurrent Primary Malignant Central Nervous System Neoplasm; Recurrent Renal Cell Carcinoma; Recurrent Rhabdomyosarcoma; Recurrent Soft Tissue Sarcoma; Recurrent Thyroid Gland Medullary Carcinoma; Refractory Adrenal Cortical Carcinoma; Refractory Alveolar Soft Part Sarcoma; Refractory Clear Cell Sarcoma of Soft Tissue; Refractory Ewing Sarcoma; Refractory Hepatoblastoma; Refractory Hepatocellular Carcinoma; Refractory Malignant Solid Neoplasm; Refractory Osteosarcoma; Refractory Primary Central Nervous System Neoplasm; Refractory Primary Malignant Central Nervous System Neoplasm; Refractory Renal Cell Carcinoma; Refractory Rhabdomyosarcoma; Refractory Soft Tissue Sarcoma; Refractory Thyroid Gland Medullary Carcinoma; Refractory Wilms Tumor; Renal Cell Carcinoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Solid Neoplasm; Thyroid Gland Medullary Carcinoma; Wilms Tumor
Interventions: Drug: Cabozantinib; Drug: Cabozantinib S-malate; Other: Pharmacological Study
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: July 15th, 2016, 11:00pm UTC
Conditions: Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortical Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Breast Metaplastic Carcinoma; Cervical Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Neuroendocrine Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Solid Neoplasm; Malignant Testicular Sex Cord-Stromal Tumor; Metastatic Malignant Neoplasm of Unknown Primary; Metastatic Pituitary Neuroendocrine Tumor; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Low Grade Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Penile Squamous Cell Carcinoma; Peritoneal Mesothelial Neoplasm; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Spindle Cell Neoplasm; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Echocardiography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab
Sponsors: National Cancer Institute (NCI)
Active, not recruiting
-
Posted: February 3rd, 2016, 1:00am UTC
Conditions: Adrenocortical Carcinoma
Interventions: Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center; Merck Sharp & Dohme LLC
Active, not recruiting
-
Posted: October 30th, 2015, 11:00pm UTC
Conditions: Differentiated Thyroid Gland Carcinoma; Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Thyroid Gland Medullary Carcinoma
Interventions: Procedure: Computed Tomography; Procedure: Dual X-ray Absorptiometry; Procedure: Physical Examination; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Cabozantinib; Drug: Lenvatinib
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Completed
-
Posted: March 30th, 2015, 11:00pm UTC
Conditions: Adrenal Gland Pheochromocytoma; Carcinoma In Situ; Central Nervous System Neoplasm; Childhood Immature Teratoma; Childhood Langerhans Cell Histiocytosis; Childhood Mature Teratoma; Congenital Mesoblastic Nephroma; Desmoid Fibromatosis; Ganglioneuroma; Lymphoproliferative Disorder; Malignant Neoplasm; Malignant Solid Neoplasm; Melanocytic Neoplasm; Myeloproliferative Neoplasm; Neoplasm of Uncertain Malignant Potential; Neuroendocrine Neoplasm; Stromal Neoplasm
Interventions: Other: Cytology Specimen Collection Procedure; Other: Medical Chart Review
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: September 3rd, 2009, 11:00pm UTC
Conditions: Von Hippel-Lindau Disease; Hemangioblastoma; Renal Cell Carcinoma; Pheochromocytoma; Pancreatic Neuroendocrine Tumor
Interventions: Other: 89Zr bevacizumab PET scan
Sponsors: University Medical Center Groningen; VHL Alliance
Completed
-
Posted: April 30th, 2008, 11:00pm UTC
Conditions: Adrenal Tumors; Adrenocortical Carcinoma; Cushing Syndrome; Conn Syndrome; Pheochromocytoma
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany); German Federal Ministry of Education and Research
Recruiting
-
Posted: December 5th, 2007, 1:00am UTC
Conditions: Adrenocortical Carcinoma
Sponsors: University of Wuerzburg
Active, not recruiting
-
Posted: April 6th, 2007, 11:00pm UTC
Conditions: Adrenocortical Carcinoma; Cushing's Syndrome
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany)
Recruiting
-
Posted: March 29th, 2007, 11:00pm UTC
Conditions: Adrenocortical Carcinoma
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany)
Recruiting
-
Posted: March 17th, 2006, 1:00am UTC
Conditions: Stage I Adrenal Cortical Carcinoma AJCC v7; Stage II Adrenal Cortical Carcinoma AJCC v7; Stage III Adrenal Cortical Carcinoma AJCC v7; Stage IV Adrenal Cortical Carcinoma AJCC v7
Interventions: Drug: Cisplatin; Procedure: Conventional Surgery; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Biological: Filgrastim; Drug: Mitotane; Biological: Pegfilgrastim
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Completed